Bendong, Avelino L.

HRN: 24-43-24  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/24/2025
10/31/2025
IV
500mg
Q8
Cholecystitis
Checking Final Appropriateness 
10/24/2025
CEFUROXIME 1.5GM (VIAL)
10/24/2025
10/31/2025
IV
1.5g
LD
Cholecystitis
Checking Final Appropriateness 
10/24/2025
CEFUROXIME 750MG (VIAL)
10/24/2025
10/31/2025
IV
750mg
Q8
Cholecystitis

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: